Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Bode, Christoph"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-16 z 16
    Tytuł:
    P 2 Y 12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells.
    Autorzy:
    Siegel PM; Department of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg - Bad Krozingen, University of Freiburg, Freiburg, Germany.; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
    Sander L; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
    Fricke A; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
    Stamm J; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
    Wang X; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.; Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia.; Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia.
    Sharma P; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
    Bassler N; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
    Ying YL; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
    Olivier CB; Department of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg - Bad Krozingen, University of Freiburg, Freiburg, Germany.
    Eisenhardt SU; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.; Department of Plastic and Hand Surgery, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Bode C; Department of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg - Bad Krozingen, University of Freiburg, Freiburg, Germany.
    Ahrens I; Department of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg - Bad Krozingen, University of Freiburg, Freiburg, Germany.; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.; Department of Cardiology and Medical Intensive Care, Augustinerinnen Hospital, Cologne, Germany.
    Diehl P; Department of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg - Bad Krozingen, University of Freiburg, Freiburg, Germany.; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.; Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia.
    Peter K; Department of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg - Bad Krozingen, University of Freiburg, Freiburg, Germany. .; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia. .; Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia. .; Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2021 Aug 31; Vol. 11 (1), pp. 17459. Date of Electronic Publication: 2021 Aug 31.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Acute Coronary Syndrome/*pathology
    Anti-Inflammatory Agents/*pharmacology
    Coronary Artery Disease/*pathology
    Inflammation/*drug therapy
    Macrophages/*drug effects
    Monocytes/*drug effects
    Purinergic P2Y Receptor Antagonists/*pharmacology
    Acute Coronary Syndrome/blood ; Adenosine Diphosphate/metabolism ; Case-Control Studies ; Coronary Artery Disease/blood ; Humans ; Inflammation/metabolism ; Inflammation/pathology ; Macrophages/metabolism ; Monocytes/metabolism ; Phosphorylation ; Receptors, Purinergic P2Y12 ; THP-1 Cells
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Inflammation in acute coronary syndrome: Expression of TLR2 mRNA is increased in platelets of patients with ACS.
    Autorzy:
    Heger LA; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Hortmann M; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Albrecht M; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Colberg C; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Peter K; Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
    Witsch T; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Stallmann D; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Zirlik A; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Cardiology, Medical University of Graz, Graz, Austria.
    Bode C; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Duerschmied D; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Ahrens I; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Cardiology and Medical Intensive Care, Augustinerinnen Hospital, Academic Teaching Hospital University of Cologne, Cologne, Germany.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2019 Oct 23; Vol. 14 (10), pp. e0224181. Date of Electronic Publication: 2019 Oct 23 (Print Publication: 2019).
    Typ publikacji:
    Clinical Trial; Journal Article
    MeSH Terms:
    Acute Coronary Syndrome/*diagnosis
    Blood Platelets/*metabolism
    Coronary Vessels/*metabolism
    Inflammation/*physiopathology
    RNA, Messenger/*genetics
    Toll-Like Receptor 2/*genetics
    Acute Coronary Syndrome/blood ; Acute Coronary Syndrome/epidemiology ; Acute Coronary Syndrome/genetics ; Aged ; Case-Control Studies ; Coronary Vessels/pathology ; Female ; Germany/epidemiology ; Humans ; Incidence ; Male ; Middle Aged ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade.
    Autorzy:
    Atar D; Department of Cardiology B, Oslo University Hospital Ullevaal, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
    Bode C
    Stuerzenbecher A
    Verheugt FW
    Pokaż więcej
    Źródło:
    Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2014 Aug; Vol. 28 (4), pp. 353-63. Date of Electronic Publication: 2014 Mar 10.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Review
    MeSH Terms:
    Acute Coronary Syndrome/*drug therapy
    Anticoagulants/*therapeutic use
    Myocardial Infarction/*drug therapy
    Acute Coronary Syndrome/physiopathology ; Acute Coronary Syndrome/prevention & control ; Anticoagulants/administration & dosage ; Humans ; Myocardial Infarction/physiopathology ; Myocardial Infarction/prevention & control ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/therapeutic use ; Prognosis ; Secondary Prevention/methods ; Thromboembolism/prevention & control ; Time Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Frequency, clinical and angiographic characteristics, and outcomes of high-risk non-ST-segment elevation acute coronary syndromes patients with left circumflex culprit lesions.
    Autorzy:
    Halim, Sharif A.
    Clare, Robert M.
    Newby, L. Kristin
    Lokhnygina, Yuliya
    Schweiger, Marc J.
    Hof, Arnoud W.
    Hochman, Judith S.
    James, Stefan K.
    White, Harvey D.
    Widimsky, Petr
    Betriu, Amadeo
    Bode, Christoph
    Giugliano, Robert P.
    Harrington, Robert A.
    Zeymer, Uwe
    Pokaż więcej
    Źródło:
    International Journal of Cardiology. Jan2016, Vol. 203, p708-713. 6p.
    Czasopismo naukowe
    Szczegóły
      Wyświetlanie 1-16 z 16

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies